Grown Rogue International (GRUSF) Current Deferred Tax Assets (2018 - 2019)
Grown Rogue International (GRUSF) recorded quarterly Current Deferred Tax Assets of -$167363.0 in Q4 2019, up 80.44% quarter-over-quarter from -$855679.0 in Q4 2018, and up 80.44% on a YoY basis from -$92752.2 in Q4 2018.
Grown Rogue International (GRUSF) Current Deferred Tax Assets (2018 - 2019) Analysis & Trends
Grown Rogue International's Current Deferred Tax Assets history runs 2 years deep, the most recent figure standing at -$167363.0 for Q4 2019.
- In Q4 2019, Current Deferred Tax Assets rose 80.44% year-over-year to -$167363.0; the TTM figure through Oct 2019 stood at -$167363.0 (up 80.44% YoY), while the FY2019 annual figure was -$167363.0, up 80.44% from the prior year.
- Current Deferred Tax Assets was -$167363.0 for Q4 2019 at Grown Rogue International, up from -$855679.0 in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $76504.0 in Q2 2018 to a low of -$855679.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2019 | -167,363.00 |
| Oct 31, 2019 | -167,363.00 |
| Oct 31, 2018 | -855,679.00 |
| Oct 31, 2018 | -855,679.00 |
| Apr 30, 2018 | 76,504.00 |
| Apr 30, 2018 | 76,504.00 |